Patients with moderate COVID-19 have a significantly increased proportion of effector CD8+ T cells and effector memory CD8+ T cells than healthy subjects and severely infected patients (Fenoglio et al., 2021), whereas naïve CD8+ T cells are reduced in old people and negatively correlated with patient age (Westmeier et al., 2020). The gene discussed is CD8A; the disease is COVID-19.